Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "Gnaiger 2013 Abstract MiP2013"

From Bioblast
Line 8: Line 8:


10 years ago the uncoupling hypothesis was presented for mitochondrial haplogroups of arctic populations suggesting that lower coupling of mitochondrial respiration to ATP production was selected for in favor of higher heat dissipation as an adaptation to cold climates [1,2]. Up to date no actual tests have been published to compare mitochondrial coupling in tissues obtained from human populations with regional mtDNA variations.  Analysis of oxidative phosphorylation (OXPHOS) is a major component of mitochondrial phenotyping [3]. We studied mitochondrial coupling in small biopsies of arm and leg muscle of Inuit of the Thule and Dorset haplogroups in northern Greenland compared to Danes from western Europe haplogroups. Inuit had a higher capacity to oxidize fat substrate in leg and arm muscle, yet mitochondrial respiration compensating for proton leak was proportionate with OXPHOS capacity. Biochemical coupling efficiency was preserved across variations in muscle fibre type and uncoupling protein-3 content.  After 42 days of skiing on the sea ice in northern Greenland, Danes demonstrated adaptive substrate control through an increase in fatty acid oxidation approaching the level of the Inuit, yet coupling control of oxidative phosphorylation was conserved. Our findings reveal that coupled ATP production is of primary evolutionary significance for muscle tissue independent of adaptations to the cold.
10 years ago the uncoupling hypothesis was presented for mitochondrial haplogroups of arctic populations suggesting that lower coupling of mitochondrial respiration to ATP production was selected for in favor of higher heat dissipation as an adaptation to cold climates [1,2]. Up to date no actual tests have been published to compare mitochondrial coupling in tissues obtained from human populations with regional mtDNA variations.  Analysis of oxidative phosphorylation (OXPHOS) is a major component of mitochondrial phenotyping [3]. We studied mitochondrial coupling in small biopsies of arm and leg muscle of Inuit of the Thule and Dorset haplogroups in northern Greenland compared to Danes from western Europe haplogroups. Inuit had a higher capacity to oxidize fat substrate in leg and arm muscle, yet mitochondrial respiration compensating for proton leak was proportionate with OXPHOS capacity. Biochemical coupling efficiency was preserved across variations in muscle fibre type and uncoupling protein-3 content.  After 42 days of skiing on the sea ice in northern Greenland, Danes demonstrated adaptive substrate control through an increase in fatty acid oxidation approaching the level of the Inuit, yet coupling control of oxidative phosphorylation was conserved. Our findings reveal that coupled ATP production is of primary evolutionary significance for muscle tissue independent of adaptations to the cold.
 
|mipnetlab=AT Innsbruck Gnaiger E, AT Innsbruck OROBOROS, AT Innsbruck MitoCom, DK Copenhagen Christiansen M, NL Maastricht Schrauwen P, DK Copenhagen Boushel RC
|mipnetlab=AT Innsbruck Gnaiger E, AT Innsbruck OROBOROS, AT Innsbruck MitoCom, DK Copenhagen Boushel RC,
}}
}}
{{Labeling
{{Labeling
|area=Respiration, mtDNA;mt-genetics, Comparative MiP;environmental MiP, Exercise physiology;nutrition;life style
|area=Respiration, mt-Biogenesis;mt-density, mtDNA;mt-genetics, Comparative MiP;environmental MiP, Exercise physiology;nutrition;life style
|organism=Human
|organism=Human
|tissues=Skeletal muscle
|tissues=Skeletal muscle
|preparations=Permeabilized tissue
|preparations=Permeabilized tissue
|enzymes=Uncoupling protein
|topics=Coupling efficiency;uncoupling, Flux control
|topics=Coupling efficiency;uncoupling, Flux control
|couplingstates=LEAK, OXPHOS, ETS
|couplingstates=LEAK, OXPHOS, ETS
Line 27: Line 27:
== Affiliations, acknowledgements and author contributions ==
== Affiliations, acknowledgements and author contributions ==


Gnaiger Erich1,2, Søndergaard H3, Munch-Andersen T4, Damsgaard R5, Hagen C4, Díez-Sånchez C5, Ara I3,6, Wright-Paradis C3,7, Schrauwen P8, Hesselink M8, Calbet J3,9, Christiansen M4, Helge JW3,10, Saltin B3, Boushel R3,11
Gnaiger Erich<sup>1,2</sup>, Søndergaard H<sup>3</sup>, Munch-Andersen T<sup>4</sup>, Damsgaard R<sup>5</sup>, Hagen C<sup>4</sup>, Díez-Sånchez C<sup>5</sup>, Ara I<sup>3,6</sup>, Wright-Paradis C<sup>3,7</sup>, Schrauwen P<sup>8</sup>, Hesselink M<sup>8</sup>, Calbet J<sup>3,9</sup>, Christiansen M<sup>4</sup>, Helge JW<sup>3,10</sup>, Saltin B<sup>3</sup>, Boushel R<sup>3,11</sup>




1D. Swarovski Research Lab, Dept. Visceral, Transplant Thoracic Surgery, Medical Univ Innsbruck; 2OROBOROS INSTRUMENTS, Innsbruck, Austria; 3Copenhagen Muscle Research Centre, Denmark; 4National Serum Institute, Copenhagen, Denmark; 5Dept. Biochem. Molec. Cell Biol., Univ. Zaragoza, Spain; 6GENUD Toledo Research Group, Univ. Castilla-La Mancha, Spain; 7Dept. Exercise Sci., Concordia Univ., Montreal, Canada; 8NUTRIM - School Nutrition, Toxicol. Metabolism, Dept. Human Biol., Maastricht Univ. Med. Center, The Netherlands; 9Dept. Physical Education, Univ. Las Palmas, Gran Canaria, Spain; 10X-Lab, Dept. Biomed. Sci., Univ. Copenhagen, Denmark; 11Dept. Biomed. Sci., Heart Circulatory Section, Univ. Copenhagen, Denmark. - [email protected]
''<sup>1</sup>D. Swarovski Research Lab, Dept. Visceral, Transplant Thoracic Surgery, Medical Univ Innsbruck; <sup>2</sup>OROBOROS INSTRUMENTS, Innsbruck, Austria; <sup>3</sup>Copenhagen Muscle Research Centre, Denmark; <sup>4</sup>National Serum Institute, Copenhagen, Denmark; <sup>5</sup>Dept. Biochem. Molec. Cell Biol., Univ. Zaragoza, Spain; <sup>6</sup>GENUD Toledo Research Group, Univ. Castilla-La Mancha, Spain; <sup>7</sup>Dept. Exercise Sci., Concordia Univ., Montreal, Canada; <sup>8</sup>NUTRIM - School Nutrition, Toxicol. Metabolism, Dept. Human Biol., Maastricht Univ. Med. Center, The Netherlands; <sup>9</sup>Dept. Physical Education, Univ. Las Palmas, Gran Canaria, Spain; <sup>10</sup>X-Lab, Dept. Biomed. Sci., Univ. Copenhagen, Denmark; <sup>11</sup>Dept. Biomed. Sci., Heart Circulatory Section, Univ. Copenhagen, Denmark.''




== Biochemical coupling Efficiency ==
== Biochemical coupling efficiency ==


Our functional test of the uncoupling hypothesis was based on a substrate-uncoupler-inhibitor titration (SUIT) protocol using high-resolution respirometry designed to interrogate coupling control in different substrate states (ETF-linked octanoylcarnitine+malate and CII-linked succinate) and compare OXPHOS capacities for ETF-, CI-, CI+II and CII-linked substrate states [3,4]. Various coupling control ratios can be derived from such experiments (respiratory acceptor control ratio, RCR=P/L; which is the inverse of the OXPHOS control ratio, L/P) which are related to but do not directly express biochemical coupling efficiency [3]. A general concept of normalization of mt-respiration is presented here, which provides an expression of biochemical coupling efficiency ranging from 0.0 at zero coupling control capacity to 1.0 at the limit of a completely coupled system.
Our functional test of the uncoupling hypothesis was based on a substrate-uncoupler-inhibitor titration ([[SUIT]]) protocol using high-resolution respirometry designed to interrogate coupling control in different substrate states ([[ETF]]-linked octanoylcarnitine+malate and [[CII]]-linked succinate) and compare OXPHOS capacities for ETF-, [[CI-]], [[CI+II]] and CII-linked substrate states [3,4]. Various coupling control ratios can be derived from such experiments (respiratory acceptor control ratio, RCR=''P/L''; which is the inverse of the OXPHOS control ratio, ''L/P'') which are related to but do not directly express biochemical coupling efficiency [3]. A general concept of normalization of mt-respiration is presented here, which provides a consistent expression of biochemical coupling Efficiency, Δ''j<sub>E-L</sub>'', ranging from 0.0 at zero coupling control capacity to 1.0 at the limit of a completely coupled system.


'''[[Flux control ratio]]s''', ''j'', are oxygen fluxes normalized relative to a common respiratory reference state [2]. For a given protocol or set of respiratory protocols, flux control ratios provide a fingerprint of coupling and substrate control independent of (i) mt-content of cells or tissues, (ii) purification in preparations of isolated mitochondria, and (iii) assay conditions for determination of tissue mass or mt-markers external to a respiratory protocol (CS, protein, stereology, etc.).  
'''[[Flux control ratio]]s''', ''j'', are oxygen fluxes normalized relative to a common respiratory reference state [2]. For a given protocol or set of respiratory protocols, flux control ratios provide a fingerprint of coupling and substrate control independent of (i) mt-content of cells or tissues, (ii) purification in preparations of isolated mitochondria, and (iii) assay conditions for determination of tissue mass or mt-markers external to a respiratory protocol (CS, protein, stereology, etc.).  


Complementary to the concept of flux control ratios and analogous to elasticities of metabolic control analysis [3], '''[[Flux control capacity|flux control capacities]]''' express the control of respiration by a specific metabolic variable, ''X'', as a dimensionless (normalized) fractional change of flux, Δ''j''. ''Z'' is the reference sate with high (stimulated or un-inhibited) flux; ''Y'' is the background state at low flux, upon which ''X'' acts (''j<sub>Y</sub>''=''Y/Z''); ''X'' is either added (stimulation, activation) or removed (reversal of inhibition) to yield a flux ''Z'' from background ''Y''. Note that ''X'', ''Y'' and ''Z'' denote both, the metabolic control variable (''X'') or respiratory state (''Y, Z'') and the corresponding respiratory flux, ''X''=''Z-Y''. Experimentally, inhibitors are added rather than removed; then ''Z'' is the reference state and ''Y'' the background state in the presence of the inhibitor. The flux control capacity of ''X'' upon background ''Y'' is expressed as the change of flux from ''Y'' to ''Z'', normalized for the reference state ''Z'':  
Complementary to the concept of flux control ratios and analogous to elasticities of metabolic control analysis [3], '''[[Flux control capacity|flux control capacities]]''' express the control of respiration by a specific metabolic variable, ''X'', as a dimensionless (normalized) fractional change of flux, Δ''j''. ''Z'' is the reference sate with high (stimulated or un-inhibited) flux; ''Y'' is the background state at low flux, upon which ''X'' acts (''j<sub>Y</sub>''=''Y/Z''); ''X'' is either added (stimulation, activation) or removed (reversal of inhibition) to yield a flux ''Z'' from background ''Y''. Note that ''X'', ''Y'' and ''Z'' denote both, the metabolic control variable (''X'') or respiratory state (''Y, Z'') ''and'' the corresponding respiratory flux, ''X''=''Z-Y''. Experimentally, inhibitors are added rather than removed; then ''Z'' is the reference state and ''Y'' the background state in the presence of the inhibitor. The flux control capacity of ''X'' upon background ''Y'' is expressed as the change of flux from ''Y'' to ''Z'', normalized for the reference state ''Z'':  


:: Δ''j<sub>Z-Y</sub>'' = (''Z-Y'')/''Z'' = 1-''j<sub>Y</sub>''
:: Δ''j<sub>Z-Y</sub>'' = (''Z-Y'')/''Z'' = 1-''j<sub>Y</sub>''
Line 46: Line 46:
Substrate control capacities express the relative change of oxygen flux in response to a transition of substrate availability in a defined coupling state. Coupling and phosphorylation control capacities are determined in an [[Substrate control state|ETS-competent substrate state]].  
Substrate control capacities express the relative change of oxygen flux in response to a transition of substrate availability in a defined coupling state. Coupling and phosphorylation control capacities are determined in an [[Substrate control state|ETS-competent substrate state]].  


Phosphorylation control capacities, i.e. LEAK (''Y=L'') to OXPHOS state (''Z=P''), were identical with ETF-linked and CII-linked substrates, in arm and leg, in Inuit and Europeans, and before and after the 42 days adaptation to life in the cold.
With ETF-linked or CII-linked substrates, [[ETS capacity]] (''E'') was not in excess of phosphorylation system capacity, such that ''P=E'' or ''P/E''=1.0. In this case, the '''[[biochemical coupling efficiency]]''' is simply related to the [[respiratory acceptor control ratio]], Δ''j<sub>E-L</sub>'' = (RCR-1)/RCR = (''P-L'')/''P''. In the present example, [[LEAK respiration]] is the background state (''Y=L'') and ''P=E'' is the reference state (''Z'').
 
Biochemical coupling efficiencies were identical with ETF-linked and CII-linked substrates, in arm and leg, in Inuit and Europeans, and before and after the 42 days adaptation to life in the cold.




Line 62: Line 64:


We would like to thank the volunteers who participated in the study. This work was sponsored by Crown Prince Frederick and supported by the John and Birthe Meyer Foundation, the Danish National Research Foundation (504-14), Fonds de le Recherche en Sante Quebec (FRSQ), and The Natural Science and Engineering Research Council of Canada (NSERC). Support was provided from the Hunter Society in Qaanaaq and Hans Jensen at Hotel Qaanaaq. The Danish and American staff at the Thule Base and the staff at the hospital in Qaanaaq and at Thule Base kindly provided technical support. Jaya Rosenmeier also provided medical support. EG was supported by K-Regio project ''[[MitoCom Tyrol]]''.
We would like to thank the volunteers who participated in the study. This work was sponsored by Crown Prince Frederick and supported by the John and Birthe Meyer Foundation, the Danish National Research Foundation (504-14), Fonds de le Recherche en Sante Quebec (FRSQ), and The Natural Science and Engineering Research Council of Canada (NSERC). Support was provided from the Hunter Society in Qaanaaq and Hans Jensen at Hotel Qaanaaq. The Danish and American staff at the Thule Base and the staff at the hospital in Qaanaaq and at Thule Base kindly provided technical support. Jaya Rosenmeier also provided medical support. EG was supported by K-Regio project ''[[MitoCom Tyrol]]''.
== Note on respiratory states ==
# Which question or concept provides the basis for studying a particular respiratory state? Example: [[OXPHOS]] capacity.
# How is a particular respiratory state obtained experimentally? Example: Addition of reduced carbon-substrate after ADP to obtain ‘[[State 3]]’, and evaluation of saturation of flux by experimental concentrations of ADP, Pi, and O2 to verify that OXPHOS capacity rather than a substrate-limited flux is measured.

Revision as of 13:43, 22 August 2013

Gnaiger E, Søndergaard H, Munch-Andersen T, Damsgaard R, Hagen C, Díez-Sånchez C, Ara I, Wright-Paradis C, Schrauwen P, Hesselink M, Calbet J, Christiansen M, Helge JW, Saltin B, Boushel R (2013) Biochemical coupling efficiency in permeabilized fibres from arm and leg muscle in Inuit versus Caucasians: A functional test of the uncoupling hypothesis in Greenland. Mitochondr Physiol Network 18.08.

Link: Flux control capacity

Gnaiger E, Soendergaard H, Munch-Andersen T, Damsgaard R, Hagen C, Diez-Sanchez C, Ara I, Wright-Paradis C, Schrauwen P, Hesselink M, Calbet J, Christiansen M, Helge JW, Saltin B, Boushel RC (2013)

Event: MiP2013

Erich Gnaiger

10 years ago the uncoupling hypothesis was presented for mitochondrial haplogroups of arctic populations suggesting that lower coupling of mitochondrial respiration to ATP production was selected for in favor of higher heat dissipation as an adaptation to cold climates [1,2]. Up to date no actual tests have been published to compare mitochondrial coupling in tissues obtained from human populations with regional mtDNA variations. Analysis of oxidative phosphorylation (OXPHOS) is a major component of mitochondrial phenotyping [3]. We studied mitochondrial coupling in small biopsies of arm and leg muscle of Inuit of the Thule and Dorset haplogroups in northern Greenland compared to Danes from western Europe haplogroups. Inuit had a higher capacity to oxidize fat substrate in leg and arm muscle, yet mitochondrial respiration compensating for proton leak was proportionate with OXPHOS capacity. Biochemical coupling efficiency was preserved across variations in muscle fibre type and uncoupling protein-3 content. After 42 days of skiing on the sea ice in northern Greenland, Danes demonstrated adaptive substrate control through an increase in fatty acid oxidation approaching the level of the Inuit, yet coupling control of oxidative phosphorylation was conserved. Our findings reveal that coupled ATP production is of primary evolutionary significance for muscle tissue independent of adaptations to the cold.


• O2k-Network Lab: AT Innsbruck Gnaiger E, AT Innsbruck OROBOROS, AT Innsbruck MitoCom, DK Copenhagen Christiansen M, NL Maastricht Schrauwen P, DK Copenhagen Boushel RC


Labels: MiParea: Respiration, mt-Biogenesis;mt-density, mtDNA;mt-genetics, Comparative MiP;environmental MiP, Exercise physiology;nutrition;life style 


Organism: Human  Tissue;cell: Skeletal muscle  Preparation: Permeabilized tissue  Enzyme: Uncoupling protein  Regulation: Coupling efficiency;uncoupling, Flux control  Coupling state: LEAK, OXPHOS, ETS"ETS" is not in the list (LEAK, ROUTINE, OXPHOS, ET) of allowed values for the "Coupling states" property. 

HRR: Oxygraph-2k, Theory 

MiP2013 


Affiliations, acknowledgements and author contributions

Gnaiger Erich1,2, Søndergaard H3, Munch-Andersen T4, Damsgaard R5, Hagen C4, Díez-Sånchez C5, Ara I3,6, Wright-Paradis C3,7, Schrauwen P8, Hesselink M8, Calbet J3,9, Christiansen M4, Helge JW3,10, Saltin B3, Boushel R3,11


1D. Swarovski Research Lab, Dept. Visceral, Transplant Thoracic Surgery, Medical Univ Innsbruck; 2OROBOROS INSTRUMENTS, Innsbruck, Austria; 3Copenhagen Muscle Research Centre, Denmark; 4National Serum Institute, Copenhagen, Denmark; 5Dept. Biochem. Molec. Cell Biol., Univ. Zaragoza, Spain; 6GENUD Toledo Research Group, Univ. Castilla-La Mancha, Spain; 7Dept. Exercise Sci., Concordia Univ., Montreal, Canada; 8NUTRIM - School Nutrition, Toxicol. Metabolism, Dept. Human Biol., Maastricht Univ. Med. Center, The Netherlands; 9Dept. Physical Education, Univ. Las Palmas, Gran Canaria, Spain; 10X-Lab, Dept. Biomed. Sci., Univ. Copenhagen, Denmark; 11Dept. Biomed. Sci., Heart Circulatory Section, Univ. Copenhagen, Denmark.

Email: [email protected]

Biochemical coupling efficiency

Our functional test of the uncoupling hypothesis was based on a substrate-uncoupler-inhibitor titration (SUIT) protocol using high-resolution respirometry designed to interrogate coupling control in different substrate states (ETF-linked octanoylcarnitine+malate and CII-linked succinate) and compare OXPHOS capacities for ETF-, CI-, CI+II and CII-linked substrate states [3,4]. Various coupling control ratios can be derived from such experiments (respiratory acceptor control ratio, RCR=P/L; which is the inverse of the OXPHOS control ratio, L/P) which are related to but do not directly express biochemical coupling efficiency [3]. A general concept of normalization of mt-respiration is presented here, which provides a consistent expression of biochemical coupling Efficiency, ΔjE-L, ranging from 0.0 at zero coupling control capacity to 1.0 at the limit of a completely coupled system.

Flux control ratios, j, are oxygen fluxes normalized relative to a common respiratory reference state [2]. For a given protocol or set of respiratory protocols, flux control ratios provide a fingerprint of coupling and substrate control independent of (i) mt-content of cells or tissues, (ii) purification in preparations of isolated mitochondria, and (iii) assay conditions for determination of tissue mass or mt-markers external to a respiratory protocol (CS, protein, stereology, etc.).

Complementary to the concept of flux control ratios and analogous to elasticities of metabolic control analysis [3], flux control capacities express the control of respiration by a specific metabolic variable, X, as a dimensionless (normalized) fractional change of flux, Δj. Z is the reference sate with high (stimulated or un-inhibited) flux; Y is the background state at low flux, upon which X acts (jY=Y/Z); X is either added (stimulation, activation) or removed (reversal of inhibition) to yield a flux Z from background Y. Note that X, Y and Z denote both, the metabolic control variable (X) or respiratory state (Y, Z) and the corresponding respiratory flux, X=Z-Y. Experimentally, inhibitors are added rather than removed; then Z is the reference state and Y the background state in the presence of the inhibitor. The flux control capacity of X upon background Y is expressed as the change of flux from Y to Z, normalized for the reference state Z:

ΔjZ-Y = (Z-Y)/Z = 1-jY

Substrate control capacities express the relative change of oxygen flux in response to a transition of substrate availability in a defined coupling state. Coupling and phosphorylation control capacities are determined in an ETS-competent substrate state.

With ETF-linked or CII-linked substrates, ETS capacity (E) was not in excess of phosphorylation system capacity, such that P=E or P/E=1.0. In this case, the biochemical coupling efficiency is simply related to the respiratory acceptor control ratio, ΔjE-L = (RCR-1)/RCR = (P-L)/P. In the present example, LEAK respiration is the background state (Y=L) and P=E is the reference state (Z).

Biochemical coupling efficiencies were identical with ETF-linked and CII-linked substrates, in arm and leg, in Inuit and Europeans, and before and after the 42 days adaptation to life in the cold.


References

  1. Mishmar D, Ruiz-Pesini E, Golik P, Macaulay V, Clark AG, Hosseini S, Brandon M, Easley K, Chen E, Brown MD, Sukernik RI, Olckers A, Wallace DC (2003) Natural selection shaped regional mtDNA variation in humans. Proc Natl Acad Sci U S A 100: 171-176.
  2. Ruiz-Pesini E, Mishmar D, Brandon M, Procaccio V, Wallace DC (2004) Effects of purifying and adaptive selection on regional variation in human mtDNA. Science 303: 223-226.
  3. Gnaiger E (2012) Mitochondrial pathways and respiratory control. An introduction to OXPHOS analysis. 3rd ed. Mitochondr Physiol Network 17.18. OROBOROS MiPNet Publications, Innsbruck: 64 pp.
  4. Pesta D, Gnaiger E (2012) High-resolution respirometry. OXPHOS protocols for human cells and permeabilized fibres from small biopisies of human muscle. Methods Mol Biol 810: 25-58.


Author contributions

E Gnaiger designed the mitochondrial respiratory protocols and analysis of flux control capacities, conducted experiments, performed data analysis; H. Søndergaard was expedition manager, conducted exercise testing, supervised all subjects throughout the study; T. Munch-Andersen conducted exercise testing, data analysis, co-supervised all subjects throughout the study; C Hagen, C Díez-Sånchez and M Christiansen performed mitochondrial haplogroup analysis; P Schrauwen and M Hesselink performed UCP3 analysis; I Ara undertook muscle fibre type analyses; R Damsgaard and J Calbet were medical monitors of the study, took muscle biopsies; JW Helge co-organized and planned the expedition; B Saltin was leader of all aspects of the study; R Boushel conducted experiments, performed data analysis.


We would like to thank the volunteers who participated in the study. This work was sponsored by Crown Prince Frederick and supported by the John and Birthe Meyer Foundation, the Danish National Research Foundation (504-14), Fonds de le Recherche en Sante Quebec (FRSQ), and The Natural Science and Engineering Research Council of Canada (NSERC). Support was provided from the Hunter Society in Qaanaaq and Hans Jensen at Hotel Qaanaaq. The Danish and American staff at the Thule Base and the staff at the hospital in Qaanaaq and at Thule Base kindly provided technical support. Jaya Rosenmeier also provided medical support. EG was supported by K-Regio project MitoCom Tyrol.